Biological Information

Background Information:

Cytochrome P450 (CYP) inhibition is one of the most common types of drug-drug interactions (DDI). When a drug inhibits a specific CYP isoform, it will reduce the metabolic activity toward a concomitant drug that is metabolized by this inhibited CYP isoform, resulting in the increase in the bioavailability of the victim drug, often to a point that toxicity is induced. Regulatory agencies have issued guidances recommending that all new molecular entity (NME) be screened for CYP inhibition liability, especially for CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. Eurofins can determine inhibition of the major CYP enzymes using drug substrates in human liver microsomes. This panel tests for inhibition of 8 CYP's (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 (midazolam and testosterone)) using a dose response of 8 concentrations for test compounds.

No. of Assays on Panel:

8

Assays on Panel:

Family

CYP450

Name

Item

5266

Protein

CYP3A4

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5267

Protein

CYP3A4

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5268

Protein

CYP2C19

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5269

Protein

CYP2D6

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5270

Protein

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5271

Protein

CYP2B6

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5272

Protein

CYP2C9

Organism

Human

Assay Sub Type

Enzymatic

Family

CYP450

Name

Item

5273

Protein

CYP2C8

Organism

Human

Assay Sub Type

Enzymatic

Family:

CYP450

Organism:

Human

Construct Details:

Microsomes

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Enzymatic

Functional Mode:

Antagonist

Detection Method:

HPLC-MS/MS

Measured Response:

Peak Area Response

Testing Information

Test Concentration / Dose:

Assay is performed with multiple concentrations (0.03, 0.1, 0.3, 1, 3, 10, 30, and 100 µM) using 2 replicates

Test Sample Requirements:

Minimum for 1) Screen: 100 μl of 10 mM stock -OR- 1 to 2 mg (pre-weighed). 2) Dose Response: 250 μl of 10 mM stock -OR- 1.5 to 2 mg (pre-weighed).

Turnaround Time

Standard:

10 Business Days

Additional Information

Brand:

Cerep

Testing Location:

Spain - Murcia

RELATED SOLUTIONS

Item: G393
Item: G397